Circulating Hematopoietic (HSC) and Very-Small Embryonic like (VSEL) Stem Cells in Newly Diagnosed Childhood Diabetes type 1 – Novel Parameters of Beta Cell Destruction/Regeneration Balance and Possible Prognostic Factors of Future Disease Course

• Published in: Stem cell reviews and reports Vol. 18; no. 5; pp. 1657 - 1667
• Main Authors: Jamiołkowska-Sztabkowska, Milena, Grubczak, Kamil, Starosz, Aleksandra, Krętowska-Grunwald, Anna, Krętowska, Magdalena, Parfienowicz, Zuzanna, Moniuszko, Marcin, Bossowski, Artur, Głowińska-Olszewska, Barbara
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2022; Springer Nature B.V
• Subjects: Beta cells; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Cell Biology; Children; Diabetes; Diabetes mellitus (insulin dependent); Embryo cells; Flow cytometry; Hematopoietic stem cells; Life Sciences; Patients; Peptides; Peripheral blood mononuclear cells; Regenerative Medicine/Tissue Engineering; Remission; Remission (Medicine); Secretion; Stem Cells; Regeneration; Type 1 diabetes; C-peptide; Stem cells; HSC; Beta cell function; VSEL; Partial remission
• ISSN: 2629-3269; 2629-3277
• DOI: 10.1007/s12015-021-10250-7

Aims/Hypothesis We aimed to evaluate hematopoietic stem cells (HSC) and very small embryonic-like stem cells (VSEL) mobilization to establish their role in residual beta cell function maintenance and partial remission occurrence in children newly diagnosed with type 1 diabetes. Methods We recruited 59 type 1 diabetic patients (aged 6–18 years) monitored for 2 years, and 31 healthy children as a control group. HSC and VSEL levels were assessed at disease onset in PBMC isolated from whole peripheral blood with the use of flow cytometry. An assessment of beta cell function was based on C-peptide secretion. Studied groups were stratified on the basis of VSEL, HSC and/or C-peptide median levels in regard to beta cell function and partial remission. Results Patients with higher stimulated C-peptide secretion at disease onset demonstrated lower levels of HSC (p < 0.05), while for VSEL and VSEL/HSC ratio higher values were observed (p < 0.05). Accordingly, after 2 years follow-up, patients with higher C-peptide secretion presented lower initial levels of HSC and higher VSEL/HSC ratio (p < 0.05). Patients with lower values of HSC levels demonstrated a tendency for better partial remission prevalence in the first 3 to 6 months after diagnosis. Conclusions These clinical observations indicate a possible significant role of HSC and VSEL in maintaining residual beta cell function in type 1 diabetic patients. Graphical Abstract